RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Results

Showing results 21 to 40 of 97.

Chapter

Reporting budget-impact analyses

August 04, 2017
Chapter

Validation

August 04, 2017
Chapter

Software and computer interface

August 04, 2017
Chapter

Creating your own budget-impact analyses today and tomorrow

August 04, 2017
Chapter

Introduction to budget-impact analysis

August 04, 2017
Chapter

Creating your own budget-impact analyses today and tomorrow

August 04, 2017
Chapter

Additional pragmatic topics

August 04, 2017
Chapter

Uncertainty analysis

August 04, 2017
Chapter

Estimating the treatment mix

August 04, 2017
Chapter

Determining the analytic framework

August 04, 2017
Chapter

Estimating the diagnosed, treated, and eligible population

August 04, 2017
Book

Budget-Impact Analysis of Health Care Interventions: A practical guide

August 04, 2017
Article

Cost-effectiveness of maintaining daily intake of oat β-glucan for coronary heart disease primary prevention

April 01, 2017
Article

Cardiovascular genetic risk testing for targeting statin therapy in the primary prevention of cardiovascular disease: A cost-effectiveness analysis

April 01, 2017
Article

Cost-effectiveness analysis of umeclidinium/vilanterol for the management of patients with moderate to very severe COPD using an economic model

March 24, 2017
Chapter

Mathematical programming modeling: An alternative to incremental cost-effectiveness analysis and budget impact analysis to optimize allocations of health care interventions

December 01, 2016
Article

A Methodological Review of US Budget-Impact Models for New Drugs

November 01, 2016
Article

Economic analysis of empiric versus diagnostic-driven strategies for immunocompromised patients with suspected fungal infections in the People's Republic of China

June 01, 2016
Article

Cost-effectiveness of Afatinib versus Erlotinib in the First-line Treatment of Patients with Metastatic Non-small Cell Lung Cancer with EGFR Exon 19 Deletion Mutations

May 01, 2016
Article

Inpatient resource use and costs associated with switching from oral antipsychotics to aripiprazole once-monthly for the treatment of schizophrenia

March 01, 2016